Open Access
| Issue |
Med Sci (Paris)
Volume 38, Number 1, Janvier 2022
|
|
|---|---|---|
| Page(s) | 25 - 27 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2021232 | |
| Published online | 21 January 2022 | |
- Fahy JV. Type 2 inflammation in asthma: present in most, absent in many. Nat Rev Immunol 2015 ; 15 : 57–65. [CrossRef] [PubMed] [Google Scholar]
- Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity 2019 ; 50 : 975–991. [CrossRef] [PubMed] [Google Scholar]
- Barnes PJ. Targeting cytokines to treat asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2018 ; 18 : 454–466. [CrossRef] [PubMed] [Google Scholar]
- Malito E, Bursulaya B, Chen C, et al. Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197. Proc Natl Acad Sci USA 2012 ; 109 : 5229–5234. [CrossRef] [PubMed] [Google Scholar]
- Ventura R, Brunner L, Heriyanto B, et al. Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia. Vaccine 2013 ; 31 : 1641–1645. [CrossRef] [PubMed] [Google Scholar]
- Bagnasco D, Ferrando M, Varricchi G, et al. A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma. Int Arch Allergy Immunol 2016 ; 170 : 122–131. [CrossRef] [PubMed] [Google Scholar]
- Hanania NA, Korenblat P, Chapman KR, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 2016 ; 4 : 781–796. [CrossRef] [PubMed] [Google Scholar]
- Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013 ; 368 : 2455–2466. [CrossRef] [PubMed] [Google Scholar]
- Conde E, Bertrand R, Balbino B, et al. Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice. Nat Commun 2021; 12 : 2574. [CrossRef] [PubMed] [Google Scholar]
- Houssiau FA, Thanou A, Mazur M, et al. IFN-alpha kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study. Ann Rheum Dis 2020; 79 : 347–55. [CrossRef] [PubMed] [Google Scholar]
- Bensussan A, Bizzini B, Pouletty P, et al. Les kinoïdes : une nouvelle génération de vaccins thérapeutiques. Med Sci (Paris) 2008 ; 24 : 306–313. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.